ADVANCE infectious diseases pharmacy through collaboration, research and education and LEAD antimicrobial stewardship to OPTIMIZE the care of patients with infections in every practice setting

Forgot password
  • Home
  • About
  • News
  • New HIV Integrase Inhibitor combination pill approved

New HIV Integrase Inhibitor combination pill approved

26 Aug 2014 10:01 AM | Christopher McCoy

Triumeq (ABACAVIR SULFATE;DOLUTEGRAVIR;LAMIVUDINE)

was approved by the FDA on August 22nd, marking the second once daily integrase combination approved but without the drug interactions and intolerances associated with cobicistat in the QUAD pill.  Information from the SINGLE trial is available from the CROI 2014 meeting and a review of the agent in N Engl J Med. 2013;369:1807-1818.


Society of Infectious Diseases Pharmacists •  PO Box 1488, Warrenville, IL 60555
(331) 248-7888 • sidp@affinity-strategies.com
Proudly Managed by Affinity Strategies

Powered by Wild Apricot Membership Software